The estimated Net Worth of David Bolocan is at least $198 Tysiąc dollars as of 26 June 2014. David Bolocan owns over 10,000 units of Cellular Biomedicine Inc stock worth over $197,500 and over the last 10 years David sold CBMG stock worth over $0.
Sign up
David Bolocan CBMG stock SEC Form 4 insiders trading
David has made over 1 trades of the Cellular Biomedicine Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently David bought 10,000 units of CBMG stock worth $50,000 on 26 June 2014.
The largest trade David's ever made was buying 10,000 units of Cellular Biomedicine Inc stock on 26 June 2014 worth over $50,000. On average, David trades about 10,000 units every 0 days since 2014. As of 26 June 2014 David still owns at least 10,000 units of Cellular Biomedicine Inc stock.
You can see the complete history of David Bolocan stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's David Bolocan's mailing address?
David's mailing address filed with the SEC is 530 UNIVERSITY AVENUE, #17, , PALO ALTO, CA, 94301.
Insiders trading at Cellular Biomedicine Inc
Over the last 13 years, insiders at Cellular Biomedicine Inc have traded over $5,441,696 worth of Cellular Biomedicine Inc stock and bought 262,367 units worth $1,621,804 . The most active insiders traders include Keith Wong, Wei (William) Cao oraz Pak To Venture Garden Ltd F.... On average, Cellular Biomedicine Inc executives and independent directors trade stock every 84 days with the average trade being worth of $911,976. The most recent stock trade was executed by Wen Tao Liu on 10 April 2018, trading 22,444 units of CBMG stock currently worth $348,555.
What does Cellular Biomedicine Inc's logo look like?
Complete history of David Bolocan stock trades at Cellular Biomedicine Inc
Cellular Biomedicine Inc executives and stock owners
Cellular Biomedicine Inc executives and other stock owners filed with the SEC include:
-
Andrew Chan,
Senior Vice President - Corporate Business Development, General Counsel, Chief Legal Officer, Secretary -
Bizuo Liu,
Chief Executive Officer, Chief Financial Officer, Director -
Yihong Yao,
Chief Scientific Officer -
Wen Liu,
Independent Director -
Terry Belmont,
Independent Chairman of the Board -
Hansheng Zhou,
Independent Director -
Chun Kwok Alan Au,
Independent Director -
Edward Schafer,
Non-Executive Independent Director -
Gang Ji,
Independent Director -
Sarah Kelly,
Director of Corporate Communications -
Darren O'Brien,
Independent Director -
Health Investment Holdings ...,
-
Wei (William) Cao,
Chief Executive Officer -
Bosun Hau,
-
Tony Liu,
CEO, CFO -
Nadir Patel,
-
Pak To Venture Garden Ltd F...,
-
David Bolocan,
Director -
Keith Wong,
Director -
Jianping Dai,
Director